Tissue and organ engineering: Investor sentiments and analysis
Startups can improve appeal by targeting long-horizon investors, outlining clinical and regulatory pathways, and generating robust, comparative evidence to support value-based reimbursement.
Authors
- Craig D'Cruz
- Deirdre C. O'Donnell
- Andrew Osterman
- Frida Velcani
- James Reohr
- Erica Keyes
- José Luis Caraveo
Institutions
- Dartmouth College (US)
- Regenerative Medicine Institute (MX)
Publication Details
- Journal
- Regenerative Therapy
- Published
- 2026-01-12
- DOI
- https://doi.org/10.1016/j.reth.2026.101066
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00